ABIONYX Pharma SA (FRA:609)

ABIONYX Pharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	139	41	41	48	68	24
Market Cap Growth	222.63%	-0.54%	-14.37%	-28.38%	178.53%	229.66%
Enterprise Value	140	39	44	49	63	17
Last Close Price	4.03	1.16	1.23	1.68	2.57	0.94
PS Ratio	32.22	9.07	8.94	9.23	100.22	-
PB Ratio	25.34	5.49	5.24	6.76	6.34	3.66
P/TBV Ratio	2630.22	20.02	16.83	28.22	12.95	3.69
EV/Sales Ratio	32.40	8.60	9.45	9.31	93.31	-
Debt / Equity Ratio	0.75	0.37	0.43	0.56	0.46	0.00
Asset Turnover	0.30	0.32	0.30	0.28	0.04	-
Inventory Turnover	17.39	17.16	21.86	28.49	-	-
Quick Ratio	1.30	1.49	1.68	1.39	1.86	2.78
Current Ratio	1.40	1.58	1.75	1.49	1.93	2.79
Return on Equity (ROE)	-61.53%	-56.76%	-46.62%	-47.14%	-67.28%	-28.37%
Return on Assets (ROA)	-20.47%	-19.67%	-13.91%	-13.64%	-23.16%	-18.07%
Return on Capital (ROIC)	-26.26%	-25.86%	-18.96%	-19.15%	-33.38%	-25.58%
Return on Capital Employed (ROCE)	-50.90%	-45.40%	-31.30%	-38.30%	-39.50%	-44.40%
Earnings Yield	-3.30%	-10.62%	-8.48%	-8.68%	-8.61%	-7.76%
FCF Yield	-2.63%	-8.97%	-9.16%	-7.27%	-10.14%	-2.89%
Buyback Yield / Dilution	-11.34%	-14.80%	-4.95%	-12.41%	-5.92%	-11.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.